The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.
Burden of illness in Parkinson's disease
Abstract
This study quantifies direct medical care costs for individual patients with Parkinson's disease (PD) and projects total national costs of PD. Anonymous, patient‐level data on health care utilization and cost were obtained from Medstat's MarketScan Research Databases. Patients were selected for study if they had either two instances of a diagnosis of PD or one diagnosis and two or more prescriptions for PD‐related medication. A control group of persons without PD was selected for comparison. Total annual health care utilization and costs were calculated for both PD patients and controls. A total of 20,016 patients with PD were identified and followed up for an average of 853 days. The mean age of the patients was 73.6 years, and 51.2% were women. Total annual direct costs were $23,101 (SD 27,529) per patient with PD versus $11,247 (SD 16,486) for controls. The regression‐adjusted incremental direct cost of PD versus control was $10,349 (95% confidence interval, 9,053, 11,645). Adding $25,326 in indirect costs, and multiplying by 645,000 cases of PD in the United States, the total cost to the nation is projected to be $23 billion annually. This estimate is higher than most previous studies, with important implications for health care delivery systems worldwide. © 2005 Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
de Rijk, M. C., Tzourio, C., Breteler, M. M., Dartigues, J. F., Amaducci, L., Lopez-Pousa, S., Manubens-Bertran, J. M., Alperovitch, A., & Rocca, W. A. (1997) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.62.1.10 · Cited by 833
Bridges, C. B., Thompson, W. W., Meltzer, M. I., Reeve, G. R., Talamonti, W. J., Cox, N. J., Lilac, H. A., Hall, H., Klimov, A., & Fukuda, K. (2000) · JAMA · doi:10.1001/jama.284.13.1655 · Cited by 651
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
The Burden of Parkinson's Disease on Society, Family, and the Individual
Whetten‐Goldstein, K., Sloan, F., Kulas, E., Cutson, T., & Schenkman, M. (1997) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1997.tb01512.x · Cited by 229
Direct economic impact of Parkinson's disease: A research survey in the United Kingdom
Findley, L., Aujla, M., Bain, P. G., Baker, M., Beech, C., Bowman, C., Holmes, J., Kingdom, W. K., MacMahon, D. G., Peto, V., et al. (2003) · Movement Disorders · doi:10.1002/mds.10507 · Cited by 227
Economic burden and quality of life impairment increase with severity of PD
Keränen, T., Kaakkola, S., Sotaniemi, K., Laulumaa, V, Haapaniemi, T., Jolma, T., Kola, H., Ylikoski, A., Satomaa, O., Kovanen, J., et al. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(02)00097-4 · Cited by 162
Burden of parkinsonism: A population‐based study
Guttman, M., Slaughter, P. M., Thériault, M. E., DeBoer, D. P., & Naylor, C. D. (2002) · Movement Disorders · doi:10.1002/mds.10333 · Cited by 145
Resource use and costs in a Swedish cohort of patients with Parkinson's disease
Hagell, P., Nordling, S., Reimer, J., Grabowski, M., & Persson, U. (2002) · Movement Disorders · doi:10.1002/mds.10262 · Cited by 123
The Economic Impact of Parkinson???s Disease
Dodel, R. C., Singer, M., Köhne-Volland, R., Szucs, T. D., Rathay, B., Scholz, E., & Oertel, W. H. (1998) · PharmacoEconomics · doi:10.2165/00019053-199814030-00006 · Cited by 113
Cost of Illness and Disease Severity in a Cohort of French Patients with Parkinson??s Disease
Pen, C. L., Wait, S., Moutard-Martin, F., Dujardin, M., & gler, M. Z. (1999) · PharmacoEconomics · doi:10.2165/00019053-199916010-00006 · Cited by 106
Berndt, E. R., Bir, A., Busch, S. H., Frank, R. G., & Normand, S. T. (2002) · Journal of Health Economics · doi:10.1016/s0167-6296(01)00132-1 · Cited by 103
The Impact of Parkinson??s Disease on Health Status, Health Expenditures, and Productivity
Rubenstein, L. M., Chrischilles, E. A., & Voelker, M. D. (1997) · PharmacoEconomics · doi:10.2165/00019053-199712040-00006 · Cited by 78
Cited by
Suitability of dysphonia measurements for telemonitoring of Parkinson’s disease
Little, M., McSharry, P., Hunter, E., Spielman, J., & Ramig, L. (2008) · Nature Precedings · doi:10.1038/npre.2008.2298.1 · Cited by 1,188
Ou, Z., Pan, J., Tang, S., Duan, D., Yu, D., Nong, H., & Wang, Z. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.776847 · Cited by 729
The current and projected economic burden of Parkinson's disease in the United States
Kowal, S. L., Dall, T. M., Chakrabarti, R., Storm, M. V., & Jain, A. (2013) · Movement Disorders · doi:10.1002/mds.25292 · Cited by 667
Current and projected future economic burden of Parkinson’s disease in the U.S.
Yang, W., Hamilton, J. L., Kopil, C., Beck, J. C., Tanner, C. M., Albin, R. L., Ray Dorsey, E., Dahodwala, N., Cintina, I., Hogan, P., et al. (2020) · npj Parkinson's Disease · doi:10.1038/s41531-020-0117-1 · Cited by 657
Environmental Toxins and Parkinson's Disease
Goldman, S. M. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135937 · Cited by 505
Metadata
- Authors
- Huse, D. M., Schulman, K., Orsini, L., Castelli‐Haley, J., Kennedy, S., & Lenhart, G.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2005-07-08
- Volume
- 20
- Issue
- 11
- Pages
- 1449-1454
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2136570995
- Cited by
- 335
- References
- 12
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.